Agalactosyl IgG [gal(o)]-an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 11, 1996, Pages 1063-1066

  Bodman Smith, K ^a   Sumar, N ^a   Sinclair, H ^a   Roitt, I ^a   Isenberg, D ^a,c   Young, A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b St Albans City Hospital

^c Arthur Stanley House   (United Kingdom)

Author keywords

Agalactosyl IgG; Prediction of disease outcome; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN G;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; MALE; MORNING STIFFNESS; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0029914789     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Parekh R, Isenberg DA, Rook G, Roitt I, Dwek R, Rademacher T. A comparative analysis of disease associated changes in the galactosylation of serum IgG. J Autoimmun 1989;2:101-14.
2. Parekh R, Isenberg DA, Roitt I, Ansell B, Dwek R, Rademacher T. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988;i:966-9.
3. Young A, Sumar N, Bodman K et al. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 1991;34:1425-9.
4. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
5. Young A, Winfield J, Williams P, Corbett M. A prognostic index for erosive changes in hands, feet and cervical spine in early rheumatoid arthritis. Br J Rheumatol 1988;27:94-101.
6. Sumar N, Bodman KB, Rademacher TW et al. Analysis of glycosylation changes in IgG using lectins. J Immunol Methods 1990;131:127-36.
7. Bodman KB, Hutchings PR, Jeddi PA et al. IgG glycosylation in autoimmune strains of mice. Clin Exp Immunol 1994;95:103-7.
8. Parekh R, Isenberg D, Roitt I, Dwek R, Rademacher T. Age-related glycosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988;167:1731-6.
9. Tomana M, Schrohenloher RE, Koopman W, Alarcon GS, Paul WA. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 1988;31:333-6.
10. Sumar N, Colaco CB, Bodman KB et al. Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis. J Autoimmun 1991;4:907-14.
11. Sumar N, Isenberg DA, Bodman KB et al. Reduction of IgG galactose in juvenile and adult onset arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann Rheum Dis 1991;50:607-10.
12. Dube R, Rook GAW, Steele J et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein in Crohn's disease, but not in ulcerative colitis. Gut 1989;31:431-4.
13. Filley E, Andreoli A, Steele J et al. A transient rise in agalactosyl IgG correlating with free IL-2 receptors during episodes of erythema nodosum leprosum. Clin Exp Immunol 1989;76:343-7.
14. O'Connor CM, Rook G, FitzGerald MX. Serum agalactosyl IgG and interleukin-6 levels in sarcoidosis. Am Rev Respir Dis 1992;145:A273.
15. Van Zeben D, Rook GAW, Hazes JMW et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol 1994;33:36-43.
16. Emery P. The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol 1995;33:765-6.